We are live on ! Find out more
ALDX icon

Aldeyra Therapeutics

84 hedge funds and large institutions have $61.1M invested in Aldeyra Therapeutics in 2020 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 19 increasing their positions, 26 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

354% more call options, than puts

Call options by funds: $454K | Put options by funds: $100K

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

67% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 18

47% more capital invested

Capital invested by funds: $41.4M → $61.1M (+$19.7M)

17% more funds holding

Funds holding: 7284 (+12)

7.38% less ownership

Funds ownership: 56.55%49.17% (-7.4%)

27% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 26

Holders
84
Holders Change
+12
Holders Change %
+16.67%
% of All Funds
1.72%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.06%
New
30
Increased
19
Reduced
26
Closed
18
Calls
$454K
Puts
$100K
Net Calls
+$354K
Net Calls Change
+$366K
Name Holding Trade Value Shares
Change
Change in
Stake
EWM
76
Edge Wealth Management
New York
$4K
Wells Fargo
77
Wells Fargo
California
$2K -$59.3K -16,236 -97%
Osaic Holdings
78
Osaic Holdings
Arizona
$2K +$1.83K +500 New
TC
79
Truvestments Capital
Florida
$2K +$1.95K +533 New
SIAP
80
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$1K
SSB
81
Sandy Spring Bank
Maryland
$1K +$1.1K +300 New
First Manhattan
82
First Manhattan
New York
$1K +$1.28K +350 New
SFM
83
Sphera Funds Management
Israel
-$2.64M -1,069,089 Closed
N
84
Nuveen
North Carolina
-$151K -61,063 Closed
Charles Schwab
85
Charles Schwab
California
-$131K -52,683 Closed
PAM
86
Panagora Asset Management
Massachusetts
-$98K -39,632 Closed
California State Teachers Retirement System (CalSTRS)
87
California State Teachers Retirement System (CalSTRS)
California
-$87K -35,132 Closed
RhumbLine Advisers
88
RhumbLine Advisers
Massachusetts
-$76K -30,784 Closed
SO
89
STRS Ohio
Ohio
-$73K -29,700 Closed
BRWA
90
B. Riley Wealth Advisors
Florida
-$55K -22,100 Closed
New York State Common Retirement Fund
91
New York State Common Retirement Fund
New York
-$43K -17,600 Closed
SIM
92
Spark Investment Management
New York
-$40K -16,300 Closed
VOYA Investment Management
93
VOYA Investment Management
Georgia
-$36K -14,390 Closed
AIG
94
American International Group
New York
-$34K -13,576 Closed
AllianceBernstein
95
AllianceBernstein
Tennessee
-$33K -13,500 Closed
Victory Capital Management
96
Victory Capital Management
Texas
-$18K -7,456 Closed
Legal & General Group
97
Legal & General Group
United Kingdom
-$10K -3,904 Closed
AIP
98
Ameritas Investment Partners
Nebraska
-$3K -1,388 Closed
MAM
99
Meeder Asset Management
Ohio
-$3K -1,043 Closed
SFS
100
Sowell Financial Services
Arkansas
+$365 +100 New

ALDX Hedge Fund Activity: Q2 2020 in Review

84 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Aldeyra Therapeutics (ALDX) for Q2 2020, worth a combined $61.1M — up 47% from $41.4M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new ALDX positions and 18 closed out — a net gain of 12 holders — while 19 added to existing stakes and 26 trimmed.

The largest buyer was Ghost Tree Capital, opening a new position worth an estimated $3.65M. The largest seller was BlackRock, cutting an estimated $4.13M.

  • 84 institutional investors held Aldeyra Therapeutics (ALDX) as of Q2 2020, up from 72 in Q1 2020.
  • Funds reported $61.1M of Aldeyra Therapeutics stock for Q2 2020, up 47% quarter-over-quarter.
  • 30 funds opened new Aldeyra Therapeutics positions in Q2 2020 and 18 closed out, a net change of +12 holders.
  • The largest Aldeyra Therapeutics buyer in Q2 2020 was Ghost Tree Capital, an estimated $3.65M added.
  • The largest Aldeyra Therapeutics seller in Q2 2020 was BlackRock, an estimated $4.13M sold.

Based on aggregated 13F filings for Q2 2020.